This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
A forum of leading hepatologists, endocrinologists and clinical development experts stewarding advances in science, clinical research and therapeutics for nonalcoholic fatty liver disease and steatohepatitis
UPCOMING EVENTS
5th NASH Roundtable™ Virtual Forum
Thursday June 16, 2022 at 11:30 AM PDT / 02:30 PM EDT
RESOURCES
Fact Sheet: NASH Roundtable, leading clinical development experts addressing challenges in NASH drug development
View Fact Sheet »MEMBER CO-AUTHORED PUBLICATIONS
April 2022
A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Read More »
April 2022
Impaired Hepatic Mitochondrial Capacity in Nonalcoholic Steatohepatitis Associated With Type 2 Diabetes. Read More »
April 2022
Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study. Read More »
March 2022
Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease. Read More »